“It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post‐Traumatic Stress Disorder
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2026
DOI: 10.1002/ajmg.b.70018 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2026. Verfasst von Brandy M Fox. Beteiligte Einrichtung: Department of Pediatrics, Stanford Medicine, Center for Biomedical Ethics, Stanford, California, USA. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Multifactorial Inheritance. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
Post‐traumatic stress disorder (PTSD) causes significant mental and physical distress, yet only a small subset of individuals exposed to trauma develop the disorder. Scientists and clinicians are still unable to predict who will get the disorder or how it will manifest. Genetic factors contribute to PTSD risk, but integrating genetic findings into clinical practice has been challenging. Military veterans are especially impacted by PTSD and have different treatment outcomes when compared to civilians. Thus, genetic findings related to PTSD may be particularly valuable to this population. This qualitative study explored expectations and concerns regarding polygenic risk score (PRS) testing for PTSD risk among three stakeholder groups: military veterans diagnosed with PTSD, clinicians who treat veterans with PTSD, and researchers specializing in PTSD genetics. Through semi‐structured interviews, I developed three themes that each convey a unique aspect of how research participants conceptualize some potential avenues for pre‐empting and living with PTSD, should PRS become widely available: (1) Controlling what you can; (2) The complexity of PTSD; (3) Potential risks for an increased emphasis on the genetic component of PTSD. Understanding stakeholder perspectives is crucial for tailoring education efforts, anticipating ethical challenges, and facilitating the responsible, equitable integration of PRS into clinical settings in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Stanford Medicine, Center for Biomedical Ethics, Stanford, California, USA.
- Department of Medical Humanities & Bioethics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas, USA.
ORCID-Profile: Brandy M Fox
Förderung
- NHGRI NIH HHS
- National Human Genome Research Institute
Zitieren
APA
Fox, B. M. (2026). “It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post‐Traumatic Stress Disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.70018
Vancouver
Fox BM. “It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post‐Traumatic Stress Disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2026. doi:10.1002/ajmg.b.70018
BibTeX
@article{Fox2026,
author = {Fox, Brandy M},
title = {“It's Not Deterministic and It Will Never Be Deterministic”: A Qualitative Study on Stakeholder Perspectives of Polygenic Risk Score Testing for Post‐Traumatic Stress Disorder},
journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
year = {2026},
doi = {10.1002/ajmg.b.70018}
}
EUVIMED